Article Text

Download PDFPDF

Short report
Biosimilar infliximab use in paediatric IBD
  1. Lisa Richmond1,
  2. Lee Curtis1,
  3. Victoria Garrick1,
  4. Pam Rogers2,
  5. Michelle Wilson3,
  6. Rachel Tayler1,
  7. Paul Henderson2,3,
  8. Richard Hansen1,
  9. David C Wilson3,
  10. Richard K Russell1
  1. 1 Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, UK
  2. 2 Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Edinburgh, UK
  3. 3 Child Life and Health, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Lisa Richmond, Paediatric Clinical Research Facility, Neurosciences building, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK; lisa.richmond{at}nhs.net

Footnotes

  • Competing interests LR: conference fees and travel from Tillotts. VG: conference fees and travel from AbbVie. RT: speaker’s fees and conference attendance from Nutricia. PH: lecture fees from Dr Falk. RH: speaker’s fees, conference support or consultancy fees from Nutricia, Dr Falk, MSD Immunology and 4D Pharma. DCW: lecture fees, consultancy, travel support from AbbVie; consultancy from Takeda; and financial support for research by MSD. RKR: speaker’s fees, travel support and participated in medical board meetings with AbbVie, Napp and Nestle. All other listed authors have no declared conflicts of interest.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests LR: conference fees and travel from Tillotts. VG: conference fees and travel from AbbVie. RT: speaker’s fees and conference attendance from Nutricia. PH: lecture fees from Dr Falk. RH: speaker’s fees, conference support or consultancy fees from Nutricia, Dr Falk, MSD Immunology and 4D Pharma. DCW: lecture fees, consultancy, travel support from AbbVie; consultancy from Takeda; and financial support for research by MSD. RKR: speaker’s fees, travel support and participated in medical board meetings with AbbVie, Napp and Nestle. All other listed authors have no declared conflicts of interest.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.